Cancer GeneticsWeb
www.cancer-genetics.org
Navigate
Disclaimer: This site is for educational purposes only; it can not be used in diagnosis or treatment.
MIC2; Antigen identified by monoclonal antibodies 12E7, F21 and O13 (Xpter-p22.32)
MIC2 Menu

    Summary Information - MIC2
    Gene Database Entries for MIC2
    Other MIC2 Related Resources
    MIC2 in the Diagnosis of Ewing's Sarcoma
    MIC2 Expression in Sex Cord-Stromal Tumours
    MIC2 and Hodgkin's Disease
    Feedback / suggest a new topic for MIC2


 Search:
  Summary Information

MIC2; Antigen identified by monoclonal antibodies 12E7, F21 and O13

Location: Xpter-p22.32
Alias: CD99

The gene product is overexpressed in Ewing's sarcoma.

Return to MIC2 Contents
 

  Gene Database Entries for MIC2

OMIM
GeneCard (Weizmann Institute)
Genbank
Swiss-Prot
Locus Link (search for MIC2)
UniGene
GenAtlas
GDB
Nomenclature (search for MIC2)

Return to MIC2 Contents
 

  Other Related Resources

Search Medline for related articles (PubMed)
  • Medline Search: cancer AND gene AND (MIC2[TI] OR CD99[TI]) (PubMed)   Limit search to: [Last Year]  Limit search to: [Last 2 Years]   Limit search to: [Reviews]
  • Return to MIC2 Contents
     

      MIC2 in the Diagnosis of Ewing's Sarcoma

    Unlike most other small blue cell tumors of childhood, Ewing's sarcoma and pPNET strongly express the MIC2(CD99) antigen. Therefore MIC2 analysis can be a useful part of the panel of tests used in the differential diagnosis of Ewing's sarcoma / pPNET.

  • Perlman EJ, et al. Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study Hum Pathol. 1994;25(3):304-7    Related articles (PubMed)

  • Devaney K, et al. MIC2 detection in tumors of bone and adjacent soft tissues Clin Orthop. 1995; (310):176-87    Related articles (PubMed)

  • Ambros IM, et al. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991; 67(7):1886-93    Related articles (PubMed)

  • Medline Search: Ewing's sarcoma AND (mic2[TI] OR cd99[TI]) (PubMed)   Limit search to: [Last Year]  Limit search to: [Last 2 Years]   Limit search to: [Reviews]

    Related Resources
    Ewing's Sarcoma Genetics
    Ewing's Sarcoma : Clinical and Epidemiological Information

    Return to MIC2 Contents
     

  •   MIC2 Expression in Sex Cord-Stromal Tumours

  • Baker RJ, et al. Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. um Pathol 1999;30(6):671-9    Related articles (PubMed)

  • Gordon MD, et al. CD99, keratin, and vimentin staining of sex cord-stromal tumors, normal ovary, and testis. Mod Pathol 1998;11(8):769-73    Related articles (PubMed)

  • Matias-Guiu X, et al. Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. um Pathol 1998;29(8):840-5    Related articles (PubMed)

  • Medline Search: sex cord stromal tumor AND (mic2[TI] OR cd99[TI]) (PubMed)   Limit search to: [Last Year]  Limit search to: [Last 2 Years]   Limit search to: [Reviews]

    Return to MIC2 Contents
     

  •   MIC2 and Hodgkin's Disease

  • Kim SH, et al. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype. Blood 2000 Jan 1;95(1):294-300    Related articles (PubMed)

  • Kim SH, et al. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2). Blood 1998 Dec 1;92(11):4287-95    Related articles (PubMed)

  • Medline Search: Hodgkin's disease AND (mic2[TI] OR cd99[TI]) (PubMed)   Limit search to: [Last Year]  Limit search to: [Last 2 Years]   Limit search to: [Reviews]

    Related Resources
    Hodgkin's Disease Genetics
    Hodgkin's Disease : Clinical and Epidemiological Information

    Return to MIC2 Contents
     

  •  [Home]   This page created: 24/11/1999  Last revised: 29/04/2003    © Copyright 1999-